A novel schiff base derivative for effective treatment of azoxymethane induced colon cancer

Basit Öğe Kaydı
dc.authoridTR112636en_US
dc.authoridTR103979en_US
dc.authoridTR34170en_US
dc.authoridTR56090en_US
dc.authoridTR40558en_US
dc.authoridTR51440en_US
dc.authoridTR13440en_US
dc.contributor.authorDoğan, Ayşegül
dc.contributor.authorBaşak, Neşe
dc.contributor.authorDemirci, Selami
dc.contributor.authorTelci, Dilek
dc.contributor.authorDede, Bülent
dc.contributor.authorTuzcu, Mehmet
dc.contributor.authorÖzercan, İbrahim Halil
dc.contributor.authorŞahin, Kazım
dc.contributor.authorŞahin, Fikrettin
dc.date.accessioned2017-04-18T06:00:54Z
dc.date.available2017-04-18T06:00:54Z
dc.date.issued2014
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThe field of cancer research has been emerged in recent years for the development of specific drugs to cancer treatment. New agents with the ability to provide efficient treatment by reducing side effects has led to new opportunities for improving agents for cytotoxic therapies. While there are several drugs for colon cancer treatment, researchers are trying to evaluate new agents or combinations of existing ones which can be used efficiently. Schiff bases with a wide range of variety and biological properties including anticancer activity might be used for colon cancer treatment. In the current study, a novel schiff base derivative synthesized by our group was tested in vivo for colon cancer. In a model of azoxymethane (AOM) induced colorectal cancer, chemopreventive properties of schiff base was also analyzed in rats. While AOM induced de novo crypt formation, adenocarcinoma and dysplasia development, schiff base application reduced the number of aberrant crypt foci (ACF), dysplasia or adenocarcinoma. Analysis of the intestinal mucosa showed that peritoneal administration of SB complex not only decreased the protein expression of COX-2, Bcl-2 and NF-κB but also enhanced the Bax expression suggesting the apoptotic and anti-proliferative effects for this compound. Our findings showed that SB complex might be used for the colorectal cancer treatment. Further studies are highly warranted to obtain additional insights and identify mode of action for the schiff base.en_US
dc.identifier.citationDoğan, A. Başak, N. Demirci, S. Telci, D. Dede, B. Tuzcu, M. Özercan, İ. H. Şahin, K. Şahin, F. (2014). A Novel Schiff Base Derivative For Effective Treatment of Azoxymethane induced colon cancer . IJPSR, 5(8): 3544-3550.en_US
dc.identifier.doi10.13040/IJPSR.0975-8232en_US
dc.identifier.endpage3550en_US
dc.identifier.issue8en_US
dc.identifier.startpage3544en_US
dc.identifier.urihttp://dx.doi.org/10.13040/IJPSR.0975-8232
dc.identifier.urihttps://hdl.handle.net/11616/6682
dc.identifier.volume5en_US
dc.language.isoenen_US
dc.publisherIJPSRen_US
dc.relation.ispartofIJPSRen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectSchiff baseen_US
dc.subjectColon canceren_US
dc.subjectAzoxymethaneen_US
dc.subjectAberrant crypt focien_US
dc.titleA novel schiff base derivative for effective treatment of azoxymethane induced colon canceren_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Makale Dosyası.pdf
Boyut:
819.65 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Sağlık Bilimleri Enstitüsü Diğer Yayınlar Koleksiyonu